Literature DB >> 14566245

Emergency hospital admissions and three-year survival of adults with and without cardiovascular surgery for congenital cardiac disease.

Harald Kaemmerer1, Sohrab Fratz, Ulrike Bauer, Erwin Oechslin, Silke Brodherr-Heberlein, Bernhard Zrenner, Juraj Turina, Rolf Jenni, Peter E Lange, John Hess.   

Abstract

OBJECTIVE: This study determined the quantity and nature of emergencies leading to unscheduled hospital admissions of adults with congenital cardiac disease and their mid-term survival.
RESULTS: During 1 year, 429 adults with congenital cardiac diseases were admitted 571 times, and 124 admissions (22%) of 95 patients (22%) were emergency admissions. Fifteen of the 95 patients were seen for the first time in 1 of the participating centers. The underlying anomalies were Fallot's tetralogy and pulmonary atresia (n = 26/7), univentricular heart after Fontan procedure (n = 25), atrial septal defect (n = 18), Eisenmenger syndrome (n = 12), complete transposition (n = 11), and others (n = 25). Indications for admission were cardiovascular complications (n = 103; 83%) (arrhythmia, cardiac failure, syncope, pacemaker problems, pericardial tamponade, and sudden death), infections (n = 8, 6%) (endocarditis, pacemaker infection, pneumonia, and cerebral abscess), acute chest pain (n = 7; 6%), and acute abdominal pain (n = 4; 3%). All patients required immediate emergency care, and 16 patients (17%) required urgent cardiovascular or abdominal surgery. Six patients died during the hospital stay. During a follow-up of 2.9 years (SD 0.8), 16 (18%) of the discharged patients died, and 2 additional patients underwent heart or heart-lung transplantation.
CONCLUSION: Adults with congenital cardiac disease often experience serious emergency situations with a high in-hospital and mid-term post-hospital mortality. Care given by physicians with special expertise is important in this specific group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 14566245     DOI: 10.1016/s0022-5223(03)00737-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  [Intensive care management of critically ill adults with congenital heart disease].

Authors:  D Bettex; M Bosshart; P G Chassot; A Rudiger
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-08-29       Impact factor: 0.840

Review 2.  Heart failure in adults with congenital heart disease: a narrative review.

Authors:  Elvin Zengin; Christoph Sinning; Christopher Blaum; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch; Paulus Kirchhof; Nigel E Drury; Victoria M Stoll
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 3.  Congenital heart defects in adulthood.

Authors:  Gerhard-Paul Diller; Günter Breithardt; Helmut Baumgartner
Journal:  Dtsch Arztebl Int       Date:  2011-07-01       Impact factor: 5.594

Review 4.  Planning Transition of Care for Adolescents Affected by Congenital Heart Disease: The Irish National Pathway.

Authors:  Pier Paolo Bassareo; Colin Joseph Mcmahon; Terence Prendiville; Adam James; Phil Roberts; Paul Oslizlok; Mark Anthony Walsh; Damien Kenny; Kevin Patrick Walsh
Journal:  Pediatr Cardiol       Date:  2022-06-23       Impact factor: 1.655

Review 5.  Anticoagulation management in adult patients with congenital heart disease: a narrative review.

Authors:  Christoph Sinning; Elvin Zengin; Gerhard Diller; Paulus Kirchhof; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

6.  Transition to adult health care for adolescents and young adults with congenital heart disease: perspectives of the patient, parent and health care provider.

Authors:  Nadia A Clarizia; Nita Chahal; Cedric Manlhiot; Jennifer Kilburn; Andrew N Redington; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

7.  Unscheduled hospitalization in adults with congenital heart disease.

Authors:  Jun Negishi; Hideo Ohuchi; Kenji Yasuda; Aya Miyazaki; Nakanishi Norifumi; Osamu Yamada
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.